No Data
No Data
RBC Capital Maintains CVS Health(CVS.US) With Buy Rating, Raises Target Price to $81
TD Cowen Maintains CVS Health(CVS.US) With Buy Rating, Raises Target Price to $95
CVS Health Corporation (CVS): Among the Best Performing Large Cap Stocks So Far in 2025
CVS Health Is Maintained at Outperform by RBC Capital
Piper Sandler Adjusts Price Target on CVS Health to $81 From $74, Maintains Overweight Rating
Express News | CVS Health Corp : RBC Raises Target Price to $81 From $74